Veltkamp, M., et al. “Infliximab or Biosimilars in Sarcoidosis; To Switch or Not to Switch?”. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, vol. 32, no. 4, Jan. 2016, pp. 280-3, https://mattioli1885journals.com/index.php/sarcoidosis/article/view/5001.